Cost-effectiveness analysis

Поделиться
HTML-код
  • Опубликовано: 17 янв 2025

Комментарии • 10

  • @monikasahay8986
    @monikasahay8986 2 года назад +1

    Crisp. To the point explanation. Thank you.

  • @kinduyemiamrew7234
    @kinduyemiamrew7234 2 года назад

    Nice presentation

  • @andrewrizal2242
    @andrewrizal2242 Год назад

    Related with the INMB, I've tried to calculate both option C and D in comparison with option A. Both of them (NMB C- NMB A) and (NMB D-NMBA) resulting the same amount, $25.000 with the 100.000 threshold. Which one should I choose between those two if we're using the NMB approach?

    • @TMSnowsill
      @TMSnowsill  11 месяцев назад

      If the net monetary benefits of C and D are identical and both greater than the net monetary benefit of A, then C and D are both optimal from the perspective of maximising QALYs with a fixed budget. It could be worthwhile exploring which has greater NMB if the willingness-to-pay is lower or higher than $100,000/QALY. There may be other differences that are important, such as equity impacts (maybe C increases health inequalities while D reduces them).

  • @kinbela
    @kinbela Год назад

    Can you check that example of "dominance?" I think we would not want to choose the dominant variable because it would be more costly and less effective. That's what I've been reading

    • @TMSnowsill
      @TMSnowsill  11 месяцев назад +1

      We would want to choose the option which is less costly and more effective. That is described as the "dominant" option. The option which is more costly and less effective is called the "dominated" option.

  • @rukaarufinu1248
    @rukaarufinu1248 2 года назад

    Thank you so much sir, much respect